Literature DB >> 27324602

Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.

Nihal Martis1, David Chirio2, Viviane Queyrel-Moranne2, Marie-Christine Zenut3, Fanny Rocher4, Jean-Gabriel Fuzibet2.   

Abstract

Entities:  

Keywords:  Biologics; Hypofibrinogenemia; Interleukin-6; Tocilizumab

Mesh：

Substances：

Year:  2016        PMID： 27324602     DOI： 10.1016/j.jbspin.2016.04.008

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  3 in total

Review 1.  Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review.

Authors:  Döndü Üsküdar Cansu; Ezgi Demirtaş; Neslihan Andiç; Hava Üsküdar Teke; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2019-03-14       Impact factor: 2.631

2.  A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia.

Authors:  Fulya Yılmaz Duran; Halil Yıldırım; Emre Mehmet Şen
Journal:  Turk J Haematol       Date:  2017-12-07       Impact factor: 1.831

Review 3.  Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis.

Authors:  Ennio G Favalli
Journal:  Rheumatol Ther       Date:  2020-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.